Affordable California-Branded Insulin to Enter National Market

Mina Kim

Mar 23, 2023 at

Save Article

Failed to save article

Please try again

(George Frey via Getty Images)

California Governor Gavin Newsom announced on Saturday a 10-year partnership with nonprofit drug company Civica Rx to manufacture the state’s own supply of insulin. Part of the state’s new CalRx program, the move is only the first step in California’s ambitious plan to produce more affordable generic prescription drugs — like overdose reversal medication naloxone — and make them available on the national market. We’ll talk about CalRx and how it could help address the nation’s drug affordability crisis.

Guests:

Angela Hart, senior correspondent covering health care politics and policy in California and the West, Kaiser Health News and California Healthline

Kevin Wren, patient advocate and volunteer, California #insulin4all

Robin Feldman, professor and director of the Center for Innovation, UC Law; author of “Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices”

Sponsored

lower waypoint

next waypoint

NPR's Sarah McCammon on Leaving the Evangelical Church KQED Youth Takeover: We’re Getting a WNBA Team Rainn Wilson from ‘The Office’ on Why We Need a Spiritual Revolution Forum From the Archives: Remembering Glide Memorial's Cecil Williams Erik Aadahl on the Power of Sound in Film KQED Youth Takeover: How Can San Jose Schools Create Safer Campuses?Supreme Court Hears Oral Arguments in Major Homelessness Case Percival Everett’s Novel “James” Recenters the Story of Huck Finn Have We Entered Into a New Cold War Era?KQED Youth Takeover: How Social Media is Changing Political Advertising